Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Can multiscale simulations unravel the function of metallo-enzymes to improve knowledge-based drug discovery?

Sgrignani J, Casalino L, Doro F, Spinello A, Magistrato A.

Future Med Chem. 2019 Apr;11(7):771-791. doi: 10.4155/fmc-2018-0495. Epub 2019 Apr 2.

PMID:
30938544
2.

Tropheryma whipplei intestinal colonization in Italian and migrant population: a retrospective observational study.

Beltrame A, Ragusa A, Perandin F, Formenti F, Fenollar F, Edouard S, Laroche M, Zavarise G, Doro F, Giorli G, Raoult D, Bisoffi Z.

Future Microbiol. 2019 Mar;14:283-292. doi: 10.2217/fmb-2018-0347. Epub 2019 Mar 11.

PMID:
30855186
3.

The Prins Reaction in the Fragrance Industry: 100th Anniversary (1919-2019).

Doro F, Akeroyd N, Schiet F, Narula A.

Angew Chem Int Ed Engl. 2019 May 27;58(22):7174-7179. doi: 10.1002/anie.201814470. Epub 2019 Apr 1. Review.

PMID:
30730597
4.

Phenotypic switching prevention and proliferation/migration inhibition of vascular smooth muscle cells by the ruthenium nitrosyl complex trans-[Ru(NO)Cl(cyclam](PF6 )2.

de Oliveira MG, Doro FG, Tfouni E, Krieger MH.

J Pharm Pharmacol. 2017 Sep;69(9):1155-1165. doi: 10.1111/jphp.12755. Epub 2017 Jun 7.

PMID:
28590566
5.

New Insights into the Molecular Mechanism of E-Cadherin-Mediated Cell Adhesion by Free Energy Calculations.

Doro F, Saladino G, Belvisi L, Civera M, Gervasio FL.

J Chem Theory Comput. 2015 Apr 14;11(4):1354-9. doi: 10.1021/ct5010164.

PMID:
26574347
6.

The Human Pathogen Streptococcus pyogenes Releases Lipoproteins as Lipoprotein-rich Membrane Vesicles.

Biagini M, Garibaldi M, Aprea S, Pezzicoli A, Doro F, Becherelli M, Taddei AR, Tani C, Tavarini S, Mora M, Teti G, D'Oro U, Nuti S, Soriani M, Margarit I, Rappuoli R, Grandi G, Norais N.

Mol Cell Proteomics. 2015 Aug;14(8):2138-49. doi: 10.1074/mcp.M114.045880. Epub 2015 May 27.

7.

Computational design of novel peptidomimetic inhibitors of cadherin homophilic interactions.

Doro F, Colombo C, Alberti C, Arosio D, Belvisi L, Casagrande C, Fanelli R, Manzoni L, Parisini E, Piarulli U, Luison E, Figini M, Tomassetti A, Civera M.

Org Biomol Chem. 2015 Mar 7;13(9):2570-3. doi: 10.1039/c4ob02538e.

8.

Rational design of small molecules as vaccine adjuvants.

Wu TY, Singh M, Miller AT, De Gregorio E, Doro F, D'Oro U, Skibinski DA, Mbow ML, Bufali S, Herman AE, Cortez A, Li Y, Nayak BP, Tritto E, Filippi CM, Otten GR, Brito LA, Monaci E, Li C, Aprea S, Valentini S, Calabrό S, Laera D, Brunelli B, Caproni E, Malyala P, Panchal RG, Warren TK, Bavari S, O'Hagan DT, Cooke MP, Valiante NM.

Sci Transl Med. 2014 Nov 19;6(263):263ra160. doi: 10.1126/scitranslmed.3009980.

9.

Ru-NO and Ru-NO2 bonding linkage isomerism in cis-[Ru(NO)(NO)(bpy)2](2+/+) complexes - a theoretical insight.

Andriani KF, Caramori GF, Doro FG, Parreira RL.

Dalton Trans. 2014 Jun 21;43(23):8792-804. doi: 10.1039/c4dt00016a.

PMID:
24781307
10.

The nature of Ru-NO bonds in ruthenium tetraazamacrocycle nitrosyl complexes--a computational study.

Caramori GF, Kunitz AG, Andriani KF, Doro FG, Frenking G, Tfouni E.

Dalton Trans. 2012 Jun 28;41(24):7327-39. doi: 10.1039/c2dt12094a. Epub 2012 May 11.

PMID:
22580477
11.

α-N-Linked glycopeptides: conformational analysis and bioactivity as lectin ligands.

Marcelo F, Cañada FJ, André S, Colombo C, Doro F, Gabius HJ, Bernardi A, Jiménez-Barbero J.

Org Biomol Chem. 2012 Aug 14;10(30):5916-23. doi: 10.1039/c2ob07135e. Epub 2012 Mar 22.

12.

Immunization with the RrgB321 fusion protein protects mice against both high and low pilus-expressing Streptococcus pneumoniae populations.

Moschioni M, De Angelis G, Harfouche C, Bizzarri E, Filippini S, Mori E, Mancuso G, Doro F, Barocchi MA, Ruggiero P, Masignani V.

Vaccine. 2012 Feb 8;30(7):1349-56. doi: 10.1016/j.vaccine.2011.12.080. Epub 2011 Dec 30.

PMID:
22210141
13.

RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodies.

Harfouche C, Filippini S, Gianfaldoni C, Ruggiero P, Moschioni M, Maccari S, Pancotto L, Arcidiacono L, Galletti B, Censini S, Mori E, Giuliani M, Facciotti C, Cartocci E, Savino S, Doro F, Pallaoro M, Nocadello S, Mancuso G, Haston M, Goldblatt D, Barocchi MA, Pizza M, Rappuoli R, Masignani V.

Infect Immun. 2012 Jan;80(1):451-60. doi: 10.1128/IAI.05780-11. Epub 2011 Nov 14.

14.

Children and adolescents treated with neridronate for osteogenesis imperfecta show no evidence of any osteonecrosis of the jaw.

Maines E, Monti E, Doro F, Morandi G, Cavarzere P, Antoniazzi F.

J Bone Miner Metab. 2012 Jul;30(4):434-8. doi: 10.1007/s00774-011-0331-3. Epub 2011 Nov 8.

PMID:
22065238
15.

Insights into molecular recognition of Lewis(X) mimics by DC-SIGN using NMR and molecular modelling.

Guzzi C, Angulo J, Doro F, Reina JJ, Thépaut M, Fieschi F, Bernardi A, Rojo J, Nieto PM.

Org Biomol Chem. 2011 Oct 26;9(22):7705-12. doi: 10.1039/c1ob05938f. Epub 2011 Oct 10.

16.

Rational design of a meningococcal antigen inducing broad protective immunity.

Scarselli M, Aricò B, Brunelli B, Savino S, Di Marcello F, Palumbo E, Veggi D, Ciucchi L, Cartocci E, Bottomley MJ, Malito E, Lo Surdo P, Comanducci M, Giuliani MM, Cantini F, Dragonetti S, Colaprico A, Doro F, Giannetti P, Pallaoro M, Brogioni B, Tontini M, Hilleringmann M, Nardi-Dei V, Banci L, Pizza M, Rappuoli R.

Sci Transl Med. 2011 Jul 13;3(91):91ra62. doi: 10.1126/scitranslmed.3002234.

17.

Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin.

Andreini M, Doknic D, Sutkeviciute I, Reina JJ, Duan J, Chabrol E, Thepaut M, Moroni E, Doro F, Belvisi L, Weiser J, Rojo J, Fieschi F, Bernardi A.

Org Biomol Chem. 2011 Aug 21;9(16):5778-86. doi: 10.1039/c1ob05573a. Epub 2011 Jul 7.

18.

Reactivity, photolability, and computational studies of the ruthenium nitrosyl complex with a substituted cyclam fac-[Ru(NO)Cl2(κ3N4,N8,N11(1-carboxypropyl)cyclam)]Cl·H2O.

Doro FG, Pepe IM, Galembeck SE, Carlos RM, da Rocha ZN, Bertotti M, Tfouni E.

Dalton Trans. 2011 Jun 28;40(24):6420-32. doi: 10.1039/c0dt01541e. Epub 2011 May 16.

PMID:
21584321
19.

Current and emerging treatments for the management of osteogenesis imperfecta.

Monti E, Mottes M, Fraschini P, Brunelli P, Forlino A, Venturi G, Doro F, Perlini S, Cavarzere P, Antoniazzi F.

Ther Clin Risk Manag. 2010 Sep 7;6:367-81.

20.

Tailoring NO donors metallopharmaceuticals: ruthenium nitrosyl ammines and aliphatic tetraazamacrocycles.

Tfouni E, Doro FG, Figueiredo LE, Pereira JC, Metzker G, Franco DW.

Curr Med Chem. 2010;17(31):3643-57. Review.

PMID:
20846113
21.

GH in combination with bisphosphonate treatment in osteogenesis imperfecta.

Antoniazzi F, Monti E, Venturi G, Franceschi R, Doro F, Gatti D, Zamboni G, Tatò L.

Eur J Endocrinol. 2010 Sep;163(3):479-87. doi: 10.1530/EJE-10-0208. Epub 2010 Jun 30.

PMID:
20592128
22.

Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1.

Doro F, Liberatori S, Rodríguez-Ortega MJ, Rinaudo CD, Rosini R, Mora M, Scarselli M, Altindis E, D'Aurizio R, Stella M, Margarit I, Maione D, Telford JL, Norais N, Grandi G.

Mol Cell Proteomics. 2009 Jul;8(7):1728-37. doi: 10.1074/mcp.M800486-MCP200. Epub 2009 Apr 28.

23.

Effects on mitochondria of mitochondria-induced nitric oxide release from a ruthenium nitrosyl complex.

Pestana CR, Phelippin DP, Polizello AC, Dorta DJ, Uyemura SA, Santos AC, Doro FG, Rodrigues FP, Tfouni E, Curti C.

Nitric Oxide. 2009 Feb;20(1):24-30. doi: 10.1016/j.niox.2008.10.001. Epub 2008 Oct 10.

PMID:
18950724
24.

Cyclam kappa4 to kappa3 ligand denticity change upon mono-n-substitution with a carboxypropyl pendant arm in a ruthenium nitrosyl complex.

Doro FG, Castellano EE, Moraes LA, Eberlin MN, Tfouni E.

Inorg Chem. 2008 May 19;47(10):4118-25. doi: 10.1021/ic702078p. Epub 2008 Apr 10.

PMID:
18399626
25.

Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coli DeltatolR IHE3034 mutant.

Berlanda Scorza F, Doro F, Rodríguez-Ortega MJ, Stella M, Liberatori S, Taddei AR, Serino L, Gomes Moriel D, Nesta B, Fontana MR, Spagnuolo A, Pizza M, Norais N, Grandi G.

Mol Cell Proteomics. 2008 Mar;7(3):473-85. Epub 2007 Nov 2.

26.
27.

Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles.

Ferrari G, Garaguso I, Adu-Bobie J, Doro F, Taddei AR, Biolchi A, Brunelli B, Giuliani MM, Pizza M, Norais N, Grandi G.

Proteomics. 2006 Mar;6(6):1856-66.

PMID:
16456881
28.

Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome.

Rodríguez-Ortega MJ, Norais N, Bensi G, Liberatori S, Capo S, Mora M, Scarselli M, Doro F, Ferrari G, Garaguso I, Maggi T, Neumann A, Covre A, Telford JL, Grandi G.

Nat Biotechnol. 2006 Feb;24(2):191-7. Epub 2006 Jan 15.

PMID:
16415855

Supplemental Content

Support Center